KRAS and neoplasm: In addition, programmed death-ligand 1 (PD-L1) expression by 22C3 immunohistochemistry was 40% positive for tumor cells, and the gene mutation analysis showed positive for Kirsten rat sarcoma viral oncogene homolog (KRAS) non-G12C mutation.